Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01198652
Other study ID # 04
Secondary ID
Status Terminated
Phase N/A
First received September 9, 2010
Last updated March 4, 2013
Start date September 2010
Est. completion date October 2012

Study information

Verified date March 2013
Source Glenveigh Medical
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This is an open, post-marketing surveillance study obtaining data retrospectively on 300 women, of any age, treated with the BD-OTS for postpartum uterine bleeding.


Recruitment information / eligibility

Status Terminated
Enrollment 300
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Treatment with the BD-OTS device

Exclusion Criteria:

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States North Austin Medical Center - St. David's Women's Center of Texas Austin Texas
United States St. David's Medical Center Austin Texas
United States Medical University of South Carolina Charleston South Carolina
United States Erlanger Chattanooga Tennessee
United States University of Cincinnati Cincinnati Ohio
United States Presbyterian/St. Luke's Medical Center Denver Colorado
United States UHS - Wilson Medical Center Johnson City New York
United States Monmouth Medical Center Long Branch New Jersey
United States Orlando Health Orlando Florida
United States Banner Good Samaritan Medical Center Phoenix Arizona
United States Toledo Hospital Toledo Ohio

Sponsors (1)

Lead Sponsor Collaborator
Glenveigh Medical

Country where clinical trial is conducted

United States,